Your browser doesn't support javascript.
loading
Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.
Béziat, Vivien; Tavernier, Simon J; Chen, Yin-Huai; Ma, Cindy S; Materna, Marie; Laurence, Arian; Staal, Jens; Aschenbrenner, Dominik; Roels, Lisa; Worley, Lisa; Claes, Kathleen; Gartner, Lisa; Kohn, Lisa A; De Bruyne, Marieke; Schmitz-Abe, Klaus; Charbonnier, Louis-Marie; Keles, Sevgi; Nammour, Justine; Vladikine, Natasha; Maglorius Renkilaraj, Majistor Raj Luxman; Seeleuthner, Yoann; Migaud, Mélanie; Rosain, Jérémie; Jeljeli, Mohamed; Boisson, Bertrand; Van Braeckel, Eva; Rosenfeld, Jill A; Dai, Hongzheng; Burrage, Lindsay C; Murdock, David R; Lambrecht, Bart N; Avettand-Fenoel, Véronique; Vogel, Tiphanie P; Esther, Charles R; Haskologlu, Sule; Dogu, Figen; Ciznar, Peter; Boutboul, David; Ouachée-Chardin, Marie; Amourette, Jean; Lebras, Marie-Noëlle; Gauvain, Clément; Tcherakian, Colas; Ikinciogullari, Aydan; Beyaert, Rudi; Abel, Laurent; Milner, Joshua D; Grimbacher, Bodo; Couderc, Louis-Jean; Butte, Manish J.
Afiliación
  • Béziat V; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Paris, France.
  • Tavernier SJ; University of Paris, Imagine Institute, Paris, France.
  • Chen YH; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
  • Ma CS; Primary Immune Deficiency Research Laboratory, Department of Internal Diseases and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
  • Materna M; VIB-UGent Center for Inflammation Research, Unit of Molecular Signal Transduction in Inflammation, Ghent, Belgium.
  • Laurence A; Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • Staal J; Department of Paediatrics, University of Oxford, Oxford, UK.
  • Aschenbrenner D; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales, Australia.
  • Roels L; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia.
  • Worley L; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Paris, France.
  • Claes K; University of Paris, Imagine Institute, Paris, France.
  • Gartner L; Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • Kohn LA; Department of Paediatrics, University of Oxford, Oxford, UK.
  • De Bruyne M; VIB-UGent Center for Inflammation Research, Unit of Molecular Signal Transduction in Inflammation, Ghent, Belgium.
  • Schmitz-Abe K; Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • Charbonnier LM; Department of Paediatrics, University of Oxford, Oxford, UK.
  • Keles S; Primary Immune Deficiency Research Laboratory, Department of Internal Diseases and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium.
  • Nammour J; Immunology Division, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales, Australia.
  • Vladikine N; St. Vincent's Clinical School, UNSW Sydney, Sydney, New South Wales, Australia.
  • Maglorius Renkilaraj MRL; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Seeleuthner Y; Translational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • Migaud M; Department of Paediatrics, University of Oxford, Oxford, UK.
  • Rosain J; Division of Immunology, Allergy, and Rheumatology, Department of Pediatrics, University of California, Los Angeles, Los Angeles, CA.
  • Jeljeli M; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
  • Boisson B; Division of Newborn Medicine and Neonatal Genomics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Van Braeckel E; Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Rosenfeld JA; The Manton Center for Orphan Disease Research, Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Dai H; Department of Pediatrics, Harvard Medical School, Boston, MA.
  • Burrage LC; Division of Immunology, Boston Children's Hospital, Boston, MA.
  • Murdock DR; Necmettin Erbakan University, Meram Medical Faculty, Division of Pediatric Allergy and Immunology, Konya, Turkey.
  • Lambrecht BN; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Paris, France.
  • Avettand-Fenoel V; University of Paris, Imagine Institute, Paris, France.
  • Vogel TP; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Paris, France.
  • Esther CR; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Paris, France.
  • Haskologlu S; University of Paris, Imagine Institute, Paris, France.
  • Dogu F; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Paris, France.
  • Ciznar P; University of Paris, Imagine Institute, Paris, France.
  • Boutboul D; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Paris, France.
  • Ouachée-Chardin M; University of Paris, Imagine Institute, Paris, France.
  • Amourette J; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Paris, France.
  • Lebras MN; University of Paris, Imagine Institute, Paris, France.
  • Gauvain C; Cochin University Hospital, Biological Immunology Unit, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, France.
  • Tcherakian C; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Paris, France.
  • Ikinciogullari A; University of Paris, Imagine Institute, Paris, France.
  • Beyaert R; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
  • Abel L; Department of Respiratory Medicine, Ghent University Hospital, Ghent Belgium.
  • Milner JD; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
  • Grimbacher B; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
  • Couderc LJ; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
  • Butte MJ; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
J Exp Med ; 217(6)2020 06 01.
Article en En | MEDLINE | ID: mdl-32207811
ABSTRACT
Autosomal dominant hyper-IgE syndrome (AD-HIES) is typically caused by dominant-negative (DN) STAT3 mutations. Patients suffer from cold staphylococcal lesions and mucocutaneous candidiasis, severe allergy, and skeletal abnormalities. We report 12 patients from 8 unrelated kindreds with AD-HIES due to DN IL6ST mutations. We identified seven different truncating mutations, one of which was recurrent. The mutant alleles encode GP130 receptors bearing the transmembrane domain but lacking both the recycling motif and all four STAT3-recruiting tyrosine residues. Upon overexpression, the mutant proteins accumulate at the cell surface and are loss of function and DN for cellular responses to IL-6, IL-11, LIF, and OSM. Moreover, the patients' heterozygous leukocytes and fibroblasts respond poorly to IL-6 and IL-11. Consistently, patients with STAT3 and IL6ST mutations display infectious and allergic manifestations of IL-6R deficiency, and some of the skeletal abnormalities of IL-11R deficiency. DN STAT3 and IL6ST mutations thus appear to underlie clinical phenocopies through impairment of the IL-6 and IL-11 response pathways.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptor gp130 de Citocinas / Genes Dominantes / Síndrome de Job / Mutación Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: J Exp Med Año: 2020 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptor gp130 de Citocinas / Genes Dominantes / Síndrome de Job / Mutación Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: J Exp Med Año: 2020 Tipo del documento: Article País de afiliación: Francia